122 related articles for article (PubMed ID: 8768457)
1. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM
Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C.
Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Durand D
Nephron; 1996; 74(3):512-6. PubMed ID: 8938673
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
4. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
Brennan DC; Stratta RJ; Lowell JA; Miller SA; Taylor RJ
Transplantation; 1994 Jun; 57(11):1606-11. PubMed ID: 8009595
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
7. [A case of allograft rejection induced by the interferon-alpha therapy to hepatitis type C after renal transplantation].
Kakimoto K; Takahara S; Kokado Y; Kameoka H; Ishibashi M; Okuyama A; Kyo M; Nagano S
Hinyokika Kiyo; 1994 Jun; 40(6):529-32. PubMed ID: 8073963
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
Jain AB; Eghtesad B; Venkataramanan R; Fontes PA; Kashyap R; Dvorchik I; Shakil AO; Kingery L; Fung JJ
Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
15. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Gane EJ; Lo SK; Riordan SM; Portmann BC; Lau JY; Naoumov NV; Williams R
Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience.
Nungaray N; Arriola M; Gutierrez MJ; Oliva E; Hernández E; Gonzalez E; Andres A; Morales JM
Transplant Proc; 2005 Nov; 37(9):3727-8. PubMed ID: 16386519
[TBL] [Abstract][Full Text] [Related]
19. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
[TBL] [Abstract][Full Text] [Related]
20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]